Posted in | News | Laser | Medical Optics

Lumenis Highlights CO2 Laser Solutions for Minimally Invasive Gynecological Surgery at 11th AAGL

Lumenis Ltd., the world's largest energy-based medical device company for surgical, ophthalmology and aesthetic applications, is showcasing its portfolio of CO2 laser solutions for minimally invasive gynecological surgery at the 11th American Association of Gynecologic Laparoscopists (AAGL) International Congress, taking place June 16-19, 2015 in Jerusalem, Israel.

A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=33729.

Lumenis' portfolio of laser systems, fibers and accessories is built on the principle that strong collaboration with the gynecology community energizes innovation and leads to better patient care.

The AcuPulse™ DUO is the only CO2 laser system that combines free beam and fiber technologies to treat a range of indications in gynecology, including endometriosis, adhesions and uterine fibroids. These gynecological conditions usually affect women during their reproductive years and are associated with pelvic pain and infertility, affecting normal sexual function and quality of life.1 The unique pulsed and continuous power and exposure mode settings of AcuPulse DUO enable optimal control over cutting, ablation and coagulation with the least amount of disturbance to adjacent tissue.

Smart tissue management is one of the main challenges in laparoscopic gynecological surgery needing to avoid perforations, adhesion formation and other potential complications when treating in close proximity to important intra-abdominal structures such as the bowel, bladder, ureter and major blood vessels.

Lumenis' broad range of advanced durable and flexible CO2 laser fibers enhance safety by providing a clear visible aiming beam that helps the surgeon target the tissue of interest, and are the only ones with a renewable tip for cost effective and user friendly operation. Along with a designated set of gynecological handpieces, they provide the thermal control and precision required for smart tissue management.

Lumenis encourages AAGL attendees to visit booth number 15 to experience the CO2 laser on a specially designated gynecological simulator in order to explore the benefits of the CO2 laser energy.

AAGL attendees are also welcome to attend a video session by Dr. Francisco Carmona, demonstrating the advantages of fiber use.

The session is entitled: "Adhesiolysis and Excision of Bladder Endometriosis using Lumenis AcuPulse CO2 Laser and FiberLase Flexible CO2 Laser Fiber," and will take place on Thursday, June 18 at 11:40 in Hall B.

"As a leading medical technology company headquartered in Israel, we are delighted that AAGL chose Jerusalem as the location for this important meeting," said Tzipi Ozer-Armon, CEO of Lumenis. "The meeting's slogan – 'where ancient history and innovative start-ups intertwine' – provides the perfect context to share our continued legacy of innovation with local healthcare professionals and international guests."

To learn more about Lumenis' CO2 laser solutions for gynecological surgery, please visit: https://vimeo.com/100938383.

Reference:
1. Meuleman C. et al., Outcome after multidisciplinary CO2 laser laparoscopic excision of deep infiltrating colorectal endometriosis (2009), Reproductive BioMedicine Online ,Vol 18. No 2. pp. 282-289.

Source: http://www.lumenis.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.